SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
Introduction To Biomedical Engineering
Start Test
Study First
Subject
:
engineering
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. What specific steps are required before market approval
IDE
What a PDP - sponsor and FDA agree on
human subject research procedure 1
mitochondria
2. Motion where angle of joint is decreased in the sagittal plane
heart rate given by (EKG)
ceramics are (5)
flexion
sagittal plane
3. Extracellular
adduction
frontal plane
classes of biomaterials (4)
Lower ion concentration of K
4. Growth phase 2
competence - informed consent
conflict of interest - informed consent
m - cell cycle
g2 - cell cycle
5. Nearer to the trunk of the body
the protocol for human subject research
proximal
how IDE's can be granted
active transport
6. As the lung grows into the pleural cavity - it picks of a layer of this
visceral pleura
milestones
pronation
the protocol for human subject research
7. Clinical evaluation of new devices are critical to prove safety
8. Neared to the end of the limbs
distal
therapeutic experiment
s - cell cycle
abduction
9. The remainder of the pleura left in the cavity
g2 - cell cycle
parietal pleura
non - therapeutic experiment example 1
two ways larger molecules pass through cell membrane
10. Considered a successful PMA
strain - e
human subject research procedure 1
a completed PDP
milestones
11. Replacement heart valves - stents - breast implants
central nervous system
lateral
class III examples
polymers (5)
12. Minors are not legally allowed to consent without approval from guardian
g1 - cell cycle
m - cell cycle
age - informed consent
if the stroke volume is less than this
13. Flexible - light - can be translucent or not transparent - can be degradable or stable - easy to work with - inexpensive
heart failure
peripheral nervous system
polymers (5)
g2 - cell cycle
14. ATP production - Kreb's cycle - contains two membranes
during external respiration -
visceral pleura
human subject research procedure 3
mitochondria
15. Institutional review board - consider the ethical aspects - to evaluate - approve - and monitor proposals to perform human research
IRB
coronary arteries
s - cell cycle
small molecules
16. Total lung capacity - vital capacity
residual volume =
visceral pleura
conflict of interest - informed consent
non - therapeutic experiment example 2
17. Toward the midline of the body
medial
functional residual capacity =
510(k) must prove this
class II examples
18. Because the devices may not state that they FDA- approved
19. Lower than for a PMA device
20. Divides the body in left and right halves; aka median plane
therapeutic experiment example 2
class III
Intracellular
midsagittal plane
21. __________ of PDP are reported to the FDA
milestones
degradation steps
pulse pressure
tumor suppressor gene
22. Rotational movement of forearm such that the palm is facing posterior when standing in anatomic position
stress - s
if the stroke volume is less than this
pronation
synovial joints have
23. Closer to the head
510(k)'s standard for clearance
functional residual capacity =
class I
superior
24. G1 - s - g2 - m
cell cycle (4)
non - therapeutic experiment
FDA
stroke volume
25. Oxygen moves from alveoli to the blood - and carbon dioxide moves from the blood to the air within alveoli
sagittal plane
during external respiration -
What a PDP - sponsor and FDA agree on
human subject research procedure 4
26. Gene which protects a cell from becoming cancerous; stops cell cycle if need DNA repair
tumor suppressor gene
PMA
peripheral nervous system
age - informed consent
27. Back view (palms up)
abduction
posterior view
rough ER
investigator
28. Translations - appropriate language - obtained in writing - and informed that they may abstain or withdraw from the study at any time
class II
informed consent documents (4)
510(k)'s standard for clearance
stroke volume
29. Programmed cell death
ER - golgi apparatus
therapeutic experiment
apoptosis
class III
30. Moderate risk to the user; most require 510(k)
class II
human subject research procedure 2
m - cell cycle
sagittal plane
31. Motion where the body part is extended from the medial line (side- to- side)
residual volume =
microtubules
abduction
polymers (5)
32. Investigational device exemption - allows companies and researches to use their new devices/technology for investigational use only - used to Generate data before PMA's
IRB
g1 - cell cycle
degradation steps
IDE
33. Food and drug administration - in charge of Regulating medical devices for their safety and effectiveness
sagittal plane
residual volume =
mean arterial pressure
FDA
34. Initiates human research study protocol - It's a document that outlines in detail scientific purpose of study - methods used - possible risks to patient - etc
investigator
two ways larger molecules pass through cell membrane
inferior
apoptosis
35. Fluid- filled cavities and are most complex and varied types of joints
stroke volume
apoptosis
Hooke's law - s
synovial joints have
36. By an IRB with or without the FDA
37. PMA - 510(k) notification - IDE - PDP
routes for registerting a new medical device in the US (4)
sacromere
class III 510(k) requiring examples
how IDE's can be granted
38. Front view (palms up)
anterior view
ER - golgi apparatus
supination
therapeutic experiment example 2
39. Closer to the feet
inferior
s - cell cycle
non - therapeutic experiment
informed consent documents (4)
40. R-R interval
classes of biomaterials (4)
why 510(k)'s standard for clearance is lower
cardiac output
heart rate given by (EKG)
41. Requires energy; move from low concentration to high concentration
active transport
510(k)'s standard for clearance
peripheral nervous system
PMA
42. The most important aspect governing the ethics of human experimentation
informed consent
PMA
routes for registerting a new medical device in the US (4)
lower ion concentration of Cl
43. No significant risk; all are exempt from needing FDA registration
class I
larger molecules require
conflict of interest - informed consent
informed consent documents (4)
44. F/ A0
stress - s
small molecules
human subject research procedure 1
frontal plane
45. Growth phase 1
g1 - cell cycle
therapeutic experiment example 1
heart rate given by (EKG)
why 510(k)'s standard for clearance is lower
46. Hollow - cylindrical structures that aid in cell division by transporting chromosomes
supination
inferior
microtubules
distal
47. lower ion concentration of Na
Intracellular
non - therapeutic experiment example 1
why 510(k)'s standard for clearance is lower
g2 - cell cycle
48. Can pass through cell membrane directly
510(k)'s standard for clearance
conflict of interest - informed consent
degradation steps
small molecules
49. DNA synthesis
parietal pleura
microtubules
s - cell cycle
What a PDP - sponsor and FDA agree on
50. Deliver oxygenated blood to cardiac tissue - derive oxygenated blood via Sinuses of Valsalva - fill with blood on diastole - heart muscle relaxes during diastole
s - cell cycle
lower ion concentration of Cl
if the stroke volume is less than this
coronary arteries